5-hydroxytryptamine 1A (5-HT 1A ) receptor agonists: A decade of empirical evidence supports their use as an efficacious therapeutic strategy for brain trauma
- 21 November 2015
- journal article
- review article
- Published by Elsevier in Brain Research
- Vol. 1640, 5-14
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Elucidating the role of 5-HT1A and 5-HT7 receptors on 8-OH-DPAT-induced behavioral recovery after experimental traumatic brain injuryNeuroscience Letters, 2012
- Biologic and Plastic Effects of Experimental Traumatic Brain Injury Treatment Paradigms and Their Relevance to Clinical RehabilitationPM&R, 2011
- Evaluation of a Combined Therapeutic Regimen of 8-OH-DPAT and Environmental Enrichment after Experimental Traumatic Brain InjuryJournal of Neurotrauma, 2010
- Empirical Comparison of Typical and Atypical Environmental Enrichment Paradigms on Functional and Histological Outcome after Experimental Traumatic Brain InjuryJournal of Neurotrauma, 2010
- Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesisNeuroscience & Biobehavioral Reviews, 2009
- Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injuryNeuroscience Letters, 2008
- Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficitsLife Sciences, 2008
- A delayed and chronic treatment regimen with the 5-HT1A receptor agonist 8-OH-DPAT after cortical impact injury facilitates motor recovery and acquisition of spatial learningBehavioural Brain Research, 2008
- The neurobehavioral benefit conferred by a single systemic administration of 8-OH-DPAT after brain trauma is confined to a narrow therapeutic windowNeuroscience Letters, 2007
- Acute treatment with the 5-HT1A receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain traumaBehavioural Brain Research, 2007